Intrinsiqs

Is Starling Oncology, Inc. overvalued?

Starling Oncology, Inc. (STLN) — key valuation metrics and fundamentals.

No verdict
Price
$6.99
Fair value
Current P/E
Normal P/E
Market cap
$698.9M
Dividend yield
0.0%
Return on equity
209.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares STLN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 16 Sep 2026.